Biologics Flashcards

(16 cards)

1
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the pharmacokinetic characteristics of TNF-C, Alefacept, Ustekinumab, Rituximab, IVIG, and Omalizumab?

A

Detailed in the relevant literature

Their label (approved) and off-label (unapproved) indications have been defined.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the main role of TNF-a in the immune response?

A

Recruitment of immune cells to the cutaneous micro-environment

TNF-a also induces secretion of metalloproteinases and pro-inflammatory cytokines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mechanism of action of TNF-a antagonists?

A

Block binding of TNF-a to its receptors, interrupting signaling pathways

This helps in reducing inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Infliximab and how does it function?

A

A chimeric antibody that binds and neutralizes both sTNF and tmTNF

It also fixes complement and induces cell apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the initial dosing protocol for Infliximab?

A

5 mg/kg at 0, 2, and 6 weeks, then every 8 weeks for maintenance

No systemic accumulation occurs upon continued treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Adalimumab and its primary mechanism?

A

A fully human monoclonal anti-TNF-a antibody that binds sTNF-a

It prevents interaction with TNFR1 and TNFR2 receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the dosing schedule for Adalimumab?

A

80 mg subcutaneously initially, followed by 40 mg every other week

Therapy should be reconsidered if no response is observed within 16 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Etanercept and how does it work?

A

A fusion protein that binds sTNF-a, preventing its receptor interaction

It alters the cytokine pattern in the immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are Golimumab and Certolizumab?

A

Golimumab is a human monoclonal antibody to TNF-a; Certolizumab is a PEGylated Fab fragment

Both are approved for rheumatoid arthritis and show efficacy in psoriatic arthritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Ustekinumab’s mechanism of action?

A

Binds to the p40 protein subunit of IL-12 and IL-23, preventing their receptor interaction

This inhibits activation of NK cells and CD4+ T-cell differentiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fill in the blank: The term ‘biologic’ refers to agents synthesized from the _______.

A

products of living organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

True or False: The safety profile of biologics is generally considered less favorable than traditional immuno-suppressive agents.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the adverse reactions associated with biologics?

A

Some are associated with significant morbidity

Initial enthusiasm has shifted to a more cautious approach.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the significance of the literature on individual anti-TNF drugs?

A

Each drug is mentioned separately due to differing actions and efficacy in diseases

Limitations for their use have also been discussed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the role of TNF receptors in the immune response?

A

They activate NF-kB, promoting inflammation and apoptosis

TNF receptors are primarily located on keratinocytes, neutrophils, endothelial cells, and fibroblasts.